Plavix Clinical Trials

Plavix (Clopidogrel) research studies recruiting patients need your help. Receive premium care & cutting edge treatments by enrolling in plavix clinical trials today.

Popular Trials

Michael Bask Gill, B Sc

Last Reviewed: October 5th, 2024

PFO Closure Device

PFO Closure Device for Migraine

Recruiting0 awards9 criteria

Denver, Colorado

This trial is testing a new device to see if it can relieve migraine headaches. The study is comparing the device to a placebo and sham (fake) device.

PD-1 Inhibitor

Pembrolizumab + Anti-platelet Therapy for Head and Neck Cancer

Recruiting1 awardPhase 1

Charleston, South Carolina

This trial is testing if combining two treatments works better than using one treatment alone for patients with head and neck cancer that has come back or spread. The combination aims to improve the immune system's ability to fight the cancer.

Cannabinoid

Hemp Product for Drug Interactions

Recruiting1 awardPhase < 1

Spokane, Washington

This trial aims to study how two different doses of CBD, given in a hemp product, affect the levels of the drug clopidogrel in the blood. The findings will guide future research and help

Antiplatelet Agent

Clopidogrel vs. Aspirin for Staph Bloodstream Infection

Recruiting3 awardsPhase 4

Montreal, Quebec

This trial aims to see if switching from aspirin to clopidogrel can improve outcomes in patients with S. aureus bacteremia. Clopidogrel may have better effects against S. aure

Antiplatelet

Clopidogrel + Aspirin for Stroke

Recruiting1 awardPhase 2

Edmonton, Alberta

"This trial aims to study the use of dual antiplatelet treatment in preventing recurrent strokes in patients who have had an ischemic stroke. Ischemic strokes are caused by a blocked blood vessel in the

Antiplatelet

Antiplatelet Therapy for Vascular Disease

Recruiting3 awardsPhase 4

New Orleans, Louisiana

This trial will investigate if patients on a blood-thinning medication (either aspirin or a P2Y12 inhibitor) are at higher risk of bleeding during a colonoscopy. Patients are often asked

Popular Filters

Trials With No Placebo

Antiplatelet Agent

Platelet Activity Assay for Blood-Thinner Monitoring in Obese Individuals

Recruiting1 awardPhase < 1

Boston, Massachusetts

This trial tests a new way to measure how well blood-thinning medication is working in people who are obese.

Antiplatelet agent

Clopidogrel for Silent Stroke

Recruiting3 awardsPhase 4

Oklahoma City, Oklahoma

This trial will test whether the drug clopidogrel can decrease the rate of new silent brain infarctions, which are linked to an increased risk for subsequent stroke and cognitive decline.

Anticoagulant

Blood Clot Prevention Therapies for COVID-19

Recruiting3 awardsPhase 4

Birmingham, Alabama

This trial is testing different ways to prevent blood clots in people who have COVID-19.

P2Y12 Inhibitor

Ticagrelor vs Clopidogrel for Coronary Artery Disease

Recruiting3 awardsPhase 4

Jacksonville, Florida

This trial is testing whether the drug ticagrelor is more effective than clopidogrel in reducing the risk of thrombotic events (blood clots) in patients who are also taking oral anticoagulants (blood thinners). A total of 63 patients will be enrolled and given either ticagrelor or clopidogrel. The trial will assess the pharmacodynamic effects of both drugs to determine which is more effective.

Antiplatelet Agent

Synergy® Stent + DAPT for Coronary Artery Disease

Recruiting3 awardsPhase 2

Scottsdale, Arizona

This trial will test if a new stent is safe for patients who are at high risk for bleeding.

Anticoagulant

Anticoagulants vs Antiplatelets for Blood Clot Prevention After Heart Procedure

Recruiting3 awardsPhase 4

Quebec

This trial compares two ways to prevent blood clots around a device used to treat heart problems. One is a short course of a blood thinner called a DOAC. The other is a daily antiplatelet pill.

View More Related Trials

Prasugrel +3 More

Ticagrelor

Clopidogrel +2 More

Dual Anti-Platelet Therapy +1 More

View more plavix clinical trials

See more medical studies focusing on plavix

Frequently Asked Questions

Do I need insurance to participate in a trial?

Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).

Is there any support for travel costs?

Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.

Will I know what medication I am taking?

This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.

How long do clinical trials last?

Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.

Do you verify all the trials on your website?

All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.

How quickly will I hear back from a clinical trial?

Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.